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Abstract
Acute pulmonary embolism (PE) is a common disease which frequently results in life-threatening right ventricular (RV) 
failure. High-risk PE, presenting with hypotension, shock, RV dysfunction or right heart thrombus is associated with a 
high mortality, particularly during the first few hours. Accordingly, it is important to commence effective therapy as 
soon as possible. In the case described in this report, a 49-year-old woman with myotonic dystrophy type 1 presented 
with acute respiratory failure and hypotension. Transthoracic echocardiography showed signs of right heart failure and 
a mobile right heart mass highly suspicious of a thrombus. Based on echocardiographic findings, acute thrombolysis 
was performed resulting in hemodynamic stabilization of the patient and complete resolution of the right heart 
thrombus. This case underscores the important role of transthoracic echocardiography for the diagnosis, management 
and monitoring of PE and underlines the efficacy and safety of thrombolysis in the treatment of PE associated with 
right heart thrombus.
Background
Right sided heart thrombi can be found in 4-18% of
patients presenting with acute pulmonary embolism
[1,2]. They may develop within the right heart chambers
or origin from peripheral venous clots that got stuck in
right heart structures on their way to the lungs. Type A
thrombi have a worm like shape, are extremely mobile
and mostly represent peripheral venous clots which tem-
porarily lodge into the right heart. Due to their extreme
mobility these clots are at high risk for severe and often
fatal pulmonary embolism. Type B thrombi which are
morphologically similar to the left heart thrombi attach
to the right atrial or ventricular wall indicating that these
thrombi mostly develop within the right heart [3,4]. The
presence of a right heart thrombus in PE is relevant for
the prognosis as it predicts a higher mortality rate (>
44%) [5].
Here, we present a case where transthoracic echocar-
diography was used for the diagnosis, management and
follow-up of pulmonary embolism with right heart
thrombus.
Case presentation
A 49-year-old woman with myotonic dystrophy type 1
(MD1, Curschmann-Steinert Syndrom) was admitted to
our neurological intensive care unit because of respira-
tory failure due to myoneuronal hypoventilation and clin-
ical suspicion of pneumonia. Due to progressive
respiratory decompensation she had to be intubated prior
to admission. At arrival, her vital signs were as follows:
body temperature 37°C, blood pressure 130/70 mmHg,
pulse 70 beats per minute (bpm) and respiratory rate 14
breaths per minute. Laboratory tests showed moderately
elevated CRP (10.95 mg/dl; normal < 0.5 mg/dl) and nor-
mal white blood cell counts. Blood and urine cultures
drawn at this time were ultimately found to be negative.
D-dimer was elevated (4.81 mg/l; normal < 0.5 mg/l).
Computed tomography (CT) of the chest was performed
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showing focal consolidations and ground glass opacity in
the left lower lobe as signs of an evolving pneumonia.
There was a filling defect in the right upper lobe pulmo-
nary artery highly suggestive of a pulmonary embolus
(See Additional file 1). Echocardiography showed a nor-
mal systolic and diastolic function of the left ventricle.
There was mild regurgitation of the mitral and pulmo-
nary valve and moderate regurgitation of the tricuspid
valve. Systolic pulmonary artery pressure (PAP) esti-
mated by measurement of systolic tricuspid regurgitation
velocity was 34 mmHg plus central venous pressure
(CVP) (Figure 1A) (See Additional file 2). Therapeutic
anticoagulation with low-molecular-weight heparin was
initiated and an antibiotic therapy with ceftriaxon and
azithromycin was continued.
On the sixth day, the respiratory and hemodynamic sit-
uation of the patient worsened acutely. The monitor ECG
showed sinus tachycardia with 130 bpm, blood pressure
was 50/30 mmHg, and the oxygen saturation decreased
to 60%. The patient could only be stabilized by adjust-
ment of ventilation parameters (controlled ventilation:
bilevel positive airway pressure mode) and high doses of
vasopressors.
Bedside transthoracic echocardiography was per-
formed immediately, showing a mobile mass (3 cm × 2
cm), highly suspicious of a thrombus, moving back and
forth from the right atrium to the ventricle through the
tricuspid orifice during cardiac cycle. The right ventricle
was severely dilated combined with right ventricular mid
free-wall hypo-/akinesis and nearly normal contraction of
the apical segment (McConnell sign) [6]. Tricuspid annu-
lar plane systolic excursion (TAPSE) was profoundly
impaired (9 mm). Tricuspid regurgitation was severe and
systolic PAP was markedly elevated (50 mmHg plus CVP)
(Figure 1B and 2) (See Additional file 3). Based on the
echocardiographic findings and on the hemodynamic
instability of the patient, therapeutic decision for acute
thrombolysis was made. A bolus of 20 mg recombinant
tissue plasminogen activator (rt-PA) was given intrave-
nously followed by 100 mg over two hours. Intravenous
fluid was administered rapidly. The hemodynamic situa-
tion of the patient stabilized over the following hour.
Echocardiography on day two after thrombolytic ther-
apy showed a complete resolution of the right sided heart
thrombus (Figure 3) See Additional file 4. Right ventricu-
lar mid free wall kinetic and function (TAPSE 16 mm)
have improved markedly. There was only a slight
improvement of systolic PAP seen on echocardiogram on
day two (46 mm Hg plus CVP) and day 14 (44 mm Hg
plus CVP) after thrombolytic therapy (Figure 1C). CT
scan of the chest two days after thrombolytic therapy
showed no severe pulmonary embolism indicating that
thrombolytic therapy was successful and the disappear-
ance of the right heart thrombus was rather due to in situ
lysis than due to migration to the pulmonary arteries.
Duplex ultrasonography of extremity veins revealed deep
vein thrombosis of the left superficial femoral vein, pro-
funda femoris vein and popliteal vein.
Heparin-induced thrombocytopenia type II and acti-
vated protein C-resistance could be excluded.
Discussion
Myotonic Dystrophy Type 1 is an autosomal dominant
multisystem disorder caused by a mutated expansion of a
CTG repeat in the 3' untranslated region of a serine-thre-
onine kinase gene on chromosome 19 [7]. MD1 patients
present with myotonia, distal weakness, frontal baldness,
diabetes, megacolon, infertility, and polychromatic cata-
ract. However, the most disabling feature of MD1 is mus-
cle wasting that leads to immobilization and
hypoventilation [8]. The most frequent cardiac manifes-
tations include myocardial thickening, heart failure, AV-
block, and torsades de pointes-tachycardia [9]. Because of
the inevitable immobilization of patients with myotonic
dystrophy they are believed to have a higher risk of
thrombosis. Despite this fact only few cases have been
published on thrombosis associated with myotonic/mus-
cular dystrophy. A small study of 69 patients with Duch-
enne muscular dystrophy in Japan found abnormal
coagulation tests in 96% of the patients. The authors sug-
gest that unknown inherent factors, immobilization and
cardiac dysfunction have an important impact on the
development of a hypercoagulable state in this disease
[10].
Acute pulmonary embolism (PE) is a common disease
that may lead to life-threatening right ventricular failure.
Computed tomography of the chest is the main diagnos-
tic approach for the detection of PE. However, in a highly
unstable patient as in our case - where transportation of
the patient is not feasible - diagnosis of PE may be
accepted solitary on the basis of direct or indirect
echocardiographic findings. Additionally, duplex ultra-
sonography of the extremities - especially in the presence
of central venous catheters - might be helpful to confirm
the diagnosis.
High-risk PE, defined by hypotension, shock or RV dys-
function, is associated with a high mortality, particularly
during the first few hours. Accordingly, it is important to
commence effective therapy as soon as possible. In stable
patients, therapy with unfractionated or low-molecular-
weight heparin is recommended. According to current
ESC guidelines, thrombolytic therapy is the first-line
treatment (unless there are contraindications for throm-
bolysis) in addition to heparin for patients with high-risk
PE presenting with cardiogenic shock and/or persistent
arterial hypotension [11].
While therapeutic strategies for the treatment of high-
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Figure 1 Pulmonary artery pressure (PAP). Continuous-wave Doppler echocardiography was used to estimate PAP: (A) on admission, (B) during 
the acute phase of pulmonary embolism with right heart thrombus, and (C) on day 2 after thrombolysis.Hewing et al. Cardiovascular Ultrasound 2010, 8:18
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heart thrombus in PE - thrombolysis, heparin alone or
embolectomy - remains an open and controversial
debate. A meta-analysis published in 2002 points to an
advantage of thrombolytic therapy in reducing mortality
compared to anticoagulation with heparin or surgical
embolectomy [12]. A more recent prospective study
found a good outcome and rapid improvement of
echocardiographic and scintigraphic parameters after
thrombolysis with rt-PA in 9 patients with mobile right
heart thrombus and massive PE [13]. In the ICOPER reg-
istry, thrombolytic treatment was the preferred option
but the 14-day mortality was still high (20.8%) (Table 1)
[1]. An additional advantage of thrombolytic therapy is
the simultaneous thrombolysis of cardiac and pulmonary
arterial thrombi as well as of deep vein thrombosis, which
may be responsible for recurring of embolisms. In our
case, thrombolytic therapy with rt-PA worked quickly,
effectively and safely resulting in a complete dissolution
of the cardiac thrombus.
Despite rapid recovery of right ventricular function
after thrombolytic therapy only a slight improvement of
systolic PAP was seen in our patient during the two weeks
follow-up. However, this short term follow-up might not
be representative for the long-term outcome regarding
pulmonary arterial pressure. Ribeiro et al. reported in
their echocardiography study of 78 patients with acute PE
and increased PAP that a stable phase of systolic PAP is
achieved within 38 days after diagnosis of acute PE. The
treatment (heparin versus thrombolysis) received in the
acute phase resulted in no significant difference in the
time to achieve the stable phase or in the level of systolic
PAP estimated for the stable phase. A systolic PAP of > 50
mmHg at the time of diagnosis of acute PE was associated
with persistent pulmonary hypertension after one year
[14].
Conclusions
Our patient was diagnosed with massive PE according to
clinical symptoms and echocardiography showing right
heart failure and a right heart thrombus. Based on these
findings, acute thrombolysis was performed resulting in
hemodynamic stabilization of the patient and complete
Figure 2 Transthoracic echocardiogram (TTE) with a right sided 
heart thrombus. Apical 4-chamber view with (A) a mobile thrombus 
(marked by arrow) in the right atrium moving through (B) the tricuspid 
orifice into (C) the right ventricle.
Figure 3 TTE on day 2 after thrombolytic therapy. Apical 4-cham-
ber view shows complete disappearance of the right heart thrombus.Hewing et al. Cardiovascular Ultrasound 2010, 8:18
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resolution of the right heart thrombus. Echocardiography
was the only possible diagnostic approach as transporta-
tion of the patient for a CT scan was not feasible due to
hemodynamic instability. Transthoracic echocardiogra-
phy is a fast, practical and sensitive approach for the
detection of right ventricular dysfunction and right heart
thrombus. Therefore it should be performed as soon as
possible in unstable patients with suspected PE.
The present case underscores the important role of
transthoracic echocardiography for the diagnosis, man-
agement and monitoring of PE. It also underlines the effi-
cacy and safety of thrombolysis in the treatment of PE
associated with right heart thrombus.
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